🕵️ Abcellera Biologics Inc. ($ABCL)
SEC insider & ownership activity, last 12 months · CIK 1703057 · every row links its SEC filing
Over the last 12 months insiders bought $2.7M with no open-market selling against it. Michael R. Hayden bought $1.1M in discretionary trades (Aug). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
4 buyers, $2.7M (9 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Michael R. Hayden | 2 | $1.1M | 0 | – | Aug 24, 2026 |
| Thermopylae Holdings Ltd. | 2 | $711K | 0 | – | Feb 27, 2026 |
| Booth Andrew | 2 | $530K | 0 | – | Aug 14, 2026 |
| John S. Montalbano | 3 | $384K | 0 | – | Aug 18, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Baker BROS. Advisors LP | 10.8% | 13G | May 7, 2026 | filing ↗ | |
| Baker BROS. Advisors (GP) LLC | 10.8% | 13G | May 7, 2026 | filing ↗ | |
| Julian C. Baker | 10.8% | 13G | May 7, 2026 | filing ↗ | |
| Felix J. Baker | 10.8% | 13G | May 7, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Aug 12, 2026 | filing ↗ |
| Other events (8.01) | Aug 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 10, 2026 | filing ↗ |
| Other events (8.01) | Aug 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2026 | filing ↗ |
| Earnings (2.02) | Aug 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 5, 2026 | filing ↗ |
| Other events (8.01) | Jul 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 29, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 30, 2026 | filing ↗ |
| Other events (8.01) | Jun 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 17, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 11, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 1, 2026 | filing ↗ |
| Earnings (2.02) | May 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 11, 2026 | filing ↗ |
| Earnings (2.02) | Feb 24, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 24, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 18, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 18, 2025 | filing ↗ |
| Auditor change (4.01) | Nov 24, 2025 | filing ↗ |